Breaking News Instant updates and real-time market news.

2020-10-28 16:38:24 FBRX Forte Biosciences $29.43 / -4.14 (-12.33%) 16:38 10/28/20 10/28 16:38 10/28/20 16:38	Forte Biosciences $30M Spot Secondary re-offered at $28.50 Ladenburg, Truist and Chardan are acting as joint book running managers for the offering.
FBRX Forte Biosciences $29.43 / -4.14 (-12.33%) 09/24/20 Chardan Forte Biosciences price target raised to $110 from $60 at Chardan 09/18/20 Chardan Seres Therapeutics downgraded to Neutral from Buy at Chardan 09/10/20 Chardan Forte Biosciences price target raised to $60 from $45 at Chardan 08/28/20 Chardan Forte Biosciences upgraded to Buy from Neutral at Chardan

2020-10-28 16:38:24

FBRX

Forte Biosciences

$29.43 / -4.14 (-12.33%)

16:38

10/28/20

10/28

16:38

10/28/20

16:38

Forte Biosciences $30M Spot Secondary re-offered at $28.50

Ladenburg, Truist and Chardan are acting as joint book running managers for the offering.

FBRX Forte Biosciences

$29.43 / -4.14 (-12.33%)

09/24/20 Chardan: Forte Biosciences price target raised to $110 from $60 at Chardan

09/18/20 Chardan: Seres Therapeutics downgraded to Neutral from Buy at Chardan

09/10/20 Chardan: Forte Biosciences price target raised to $60 from $45 at Chardan

08/28/20 Chardan: Forte Biosciences upgraded to Buy from Neutral at Chardan

TODAY'S FREE FLY STORIES

Periodicals	State Street to eliminate 1,200 positions this year, BI reports » 11:47 01/20/21 01/20 11:47 01/20/21 11:47 STT State Street $77.70 / -0.82 (-1.04%) State Street Corp. is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events STT State Street $77.70 / -0.82 (-1.04%) 01/19/21 State Street sees Q1 NII down about 68% sequentially 01/19/21 State Street sees Q1 fee revenue down y/y by low single digits 01/19/21 State Street board reinitiates share repurchase program of up to $475M in Q1 01/19/21 State Street faced 'a number of unprecedented challenges' in 2020 STT State Street $77.70 / -0.82 (-1.04%) 06:43 Today RBC Capital State Street price target raised to $86 from $78 at RBC Capital 01/11/21 Piper Sandler State Street price target raised to $81 from $69 at Piper Sandler 01/05/21 Wolfe Research State Street downgraded to Underperform from Peer Perform at Wolfe Research 01/05/21 Goldman Sachs State Street downgraded to Neutral from Buy at Goldman Sachs STT State Street $77.70 / -0.82 (-1.04%) 01/19/21 State Street reports Q4 EPS $1.39, consensus $1.56 10/16/20 State Street reports Q3 EPS $1.45, consensus $1.41 10/15/20 Notable companies reporting before tomorrow's open 10/15/20 Notable companies reporting before tomorrow's open STT State Street $77.70 / -0.82 (-1.04%) 12/11/20 State Street weighs strategic options for asset management unit, Bloomberg says 12/11/20 State Street weighs strategic options for asset management unit, Bloomberg says STT State Street $77.70 / -0.82 (-1.04%) 10/16/20 Fly Intel: Pre-market Movers 02/24/21 22nd Annual Virtual Financial Services Forum
Options	Spirit Airlines call volume above normal and directionally bullish » 11:45 01/20/21 01/20 11:45 01/20/21 11:45 SAVE Spirit Airlines $27.29 / +0.605 (+2.27%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options SAVE Spirit Airlines $27.29 / +0.605 (+2.27%) 10/29/20 Spirit 'not ready' to make a call on what will happen with A319s near-term 10/29/20 Spirit Airlines sees potential to resume growth in mid-2021 10/29/20 Spirit Airlines plans to keep fleet of 31 A319s parked into 2021 10/29/20 Spirit Airlines sees FY21 CapEx about $100M-$125M SAVE Spirit Airlines $27.29 / +0.605 (+2.27%) 01/14/21 Susquehanna Spirit Airlines price target raised to $22 from $19 at Susquehanna 01/08/21 BofA Spirit Airlines upgraded to Neutral from Underperform at BofA 12/23/20 Citi Airline demand in early 2021 'looks soft,' says Citi 12/16/20 Fly Intel: Top five analyst downgrades SAVE Spirit Airlines $27.29 / +0.605 (+2.27%) 10/29/20 Spirit Airlines sees total Q4 revenue down 43%-45% y/y, consensus $453.93M 10/28/20 Spirit Airlines reports Q3 EPS ($1.07), consensus ($2.72) 10/28/20 Notable companies reporting after market close 07/22/20 Spirit Airlines reports Q2 adj. EPS ($3.59), consensus ($2.66) 08 May SAVE Spirit Airlines $27.29 / +0.605 (+2.27%) 01/18/21 Biden to block Trump's plan to lift COVID travel restrictions, Reuters reports 01/18/21 Trump lifting COVID travel restrictions on Europe/Brazil, Reuters reports 01/15/21 U.K. tightens borders to prevent arrival of new COVID strains, Reuters says 01/12/21 U.S. to expand proof of no COVID rule to all international visitors, WSJ says SAVE Spirit Airlines $27.29 / +0.605 (+2.27%) 10/28/20 Fly Intel: After-Hours Movers SAVE Spirit Airlines $27.29 / +0.605 (+2.27%) 01/14/21 Spirit Airlines call volume above normal and directionally bullish 11/16/20 Unusually active option classes on open November 16th 11/05/20 Spirit Airlines call volume above normal and directionally bullish 10/20/20 Spirit Airlines call volume above normal and directionally bullish
Recommendations	LafargeHolcim price target raised to CHF 57 from CHF 48 at UBS » 11:39 01/20/21 01/20 11:39 01/20/21 11:39 HCMLY LafargeHolcim $0.00 / + (+0.00%) UBS analyst Gregor… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Periodicals HCMLY LafargeHolcim $0.00 / + (+0.00%) 01/14/21 Berenberg LafargeHolcim initiated with a Hold at Berenberg 01/08/21 JPMorgan LafargeHolcim price target raised to CHF 59 from CHF 51 at JPMorgan 12/07/20 Jefferies LafargeHolcim initiated with a Hold at Jefferies 11/18/20 Deutsche Bank LafargeHolcim initiated with a Buy at Deutsche Bank HCMLY LafargeHolcim $0.00 / + (+0.00%) 01/04/21 LafargeHolcim in talks to acquire Bridgestone unit, Bloomberg says
Recommendations	HeidelbergCement price target raised to EUR 71.50 from EUR 68.50 at UBS » 11:38 01/20/21 01/20 11:38 01/20/21 11:38 HDELY HeidelbergCement $0.00 / + (+0.00%) UBS analyst Gregor… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research HDELY HeidelbergCement $0.00 / + (+0.00%) 01/14/21 Berenberg HeidelbergCement initiated with a Buy at Berenberg 01/08/21 JPMorgan HeidelbergCement price target raised to EUR 70 from EUR 60 at JPMorgan 01/06/21 Societe Generale HeidelbergCement upgraded to Buy from Hold at Societe Generale 12/16/20 Credit Suisse HeidelbergCement price target raised to EUR 69 from EUR 60 at Credit Suisse
Recommendations	GlaxoSmithKline price target raised to 1,450 GBp from 1,440 GBp at UBS » 11:38 01/20/21 01/20 11:38 01/20/21 11:38 GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) UBS analyst Laura… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 01/12/21 Vir Biotechnology, GlaxoSmithKline to evaluate VIR-7832 in COVID-19 patients 01/11/21 Eligo Bioscience enters research, option agreement with GlaxoSmithKline 12/21/20 Ligand, GSK in pact 'leveraging' Icagen's small molecule 'expertise' 12/17/20 Hikma Pharmaceuticals launches generic Advair Diskus following FDA approval GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 09:56 Today Fly Intel: Top five analyst downgrades 06:32 Today Credit Suisse GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse 05:29 Today Credit Suisse GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse 01/15/21 Deutsche Bank GlaxoSmithKline initiated with a Hold at Deutsche Bank GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 10/28/20 GlaxoSmithKline now sees 2020 adjusted EPS at lower end of down 1%-4% range 10/28/20 GlaxoSmithKline reports Q3 adjusted EPS 35.6p vs. 38.6p a year ago 10/08/20 GlaxoSmithKline sees impact of foreign exchange on Q3 sales of about 5% 07/29/20 GlaxoSmithKline reports Q2 adjusted EPS 19.2p, down 37% AER GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 01/12/21 GSK looks to double blockbusters in portfolio by 2026, Bloomberg says 12/31/20 Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 12/11/20 GlaxoSmithKline offered $120 per share for Eidos Therapeutics, Bloomberg says GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 09/08/20 Moderna slides as analyst says sell on rising COVID vaccine competition 03/03/21 2021 London Global Healthcare Virtual Conference 02/03/21 GlaxoSmithKline - GSK GSK GlaxoSmithKline $37.81 / -0.72 (-1.87%) 09/04/20 GlaxoSmithKline call volume above normal and directionally bullish 08/03/20 Unusually active option classes on open August 3rd 07/31/20 Unusually active option classes on open July 31st

Hot Stocks	First Eagle Alternative Credit COO, CFO Terry Olson to retire » 11:38 01/20/21 01/20 11:38 01/20/21 11:38 FCRD First Eagle Alternative Capital $3.70 / +0.03 (+0.82%) First Eagle Alternative… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News FCRD First Eagle Alternative Capital $3.70 / +0.03 (+0.82%) 11/16/20 Omega takes Alphabet Class A stake, exits position in JPMorgan
Recommendations	Ferguson price target raised to 10,050 GBp from 9,450 GBp at UBS » 11:37 01/20/21 01/20 11:37 01/20/21 11:37 FERGY Ferguson $0.00 / + (+0.00%) UBS analyst Gregor… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research FERGY Ferguson $0.00 / + (+0.00%) 01/14/21 Berenberg Ferguson downgraded to Sell from Hold at Berenberg 01/05/21 UBS Ferguson U.K. sale not that material, says UBS 01/05/21 RBC Capital Ferguson forecasts adjusted at RBC Capital 12/09/20 Barclays Ferguson price target raised to 9,000 GBp from 8,000 GBp at Barclays
Recommendations	CRH price target raised to 3,600 GBp from 3,450 GBp at UBS » 11:37 01/20/21 01/20 11:37 01/20/21 11:37 CRH CRH $44.88 / -0.12 (-0.27%) UBS analyst Gregor… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals CRH CRH $44.88 / -0.12 (-0.27%) 09/21/20 Ash Grove to upgrade import terminal in Florida CRH CRH $44.88 / -0.12 (-0.27%) 01/14/21 Berenberg CRH initiated with a Hold at Berenberg 01/08/21 JPMorgan CRH price target raised to EUR 41 from EUR 40 at JPMorgan 01/06/21 Societe Generale CRH upgraded to Buy on apparent Democratic majority at Societe Generale 01/06/21 Societe Generale CRH upgraded to Buy from Hold at Societe Generale CRH CRH $44.88 / -0.12 (-0.27%) 12/23/20 HeidelbergCement working to sell California operations, Bloomberg reports
Recommendations	Bankinter price target raised to EUR 4.60 from EUR 3.45 at UBS » 11:36 01/20/21 01/20 11:36 01/20/21 11:36 BKIMF Bankinter $0.00 / + (+0.00%) UBS analyst Ignacio… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research BKIMF Bankinter $0.00 / + (+0.00%) 12/14/20 JPMorgan Bankinter price target raised to EUR 3.60 from EUR 3.30 at JPMorgan 11/24/20 Morgan Stanley Bankinter price target raised to EUR 4.15 from EUR 3.90 at Morgan Stanley 10/23/20 Barclays Bankinter price target lowered to EUR 3.60 from EUR 3.80 at Barclays 10/23/20 UBS Bankinter price target lowered to EUR 3.45 from EUR 3.55 at UBS
Recommendations	Bankia price target raised to EUR 1.52 from EUR 1.09 at UBS » 11:36 01/20/21 01/20 11:36 01/20/21 11:36 BNKXF Bankia $0.00 / + (+0.00%) UBS analyst Ignacio… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals BNKXF Bankia $0.00 / + (+0.00%) 09/18/20 CaixaBank to acquire Bankia for exchange ratio of 0.6845 shares BNKXF Bankia $0.00 / + (+0.00%) 12/14/20 JPMorgan Bankia price target raised to EUR 1.20 from EUR 1.10 at JPMorgan 11/25/20 HSBC Bankia downgraded to Hold from Buy at HSBC 10/29/20 UBS Bankia price target lowered to EUR 1.09 from EUR 1.15 at UBS 10/20/20 UBS Bankia price target lowered to EUR 1.15 from EUR 1.30 at UBS BNKXF Bankia $0.00 / + (+0.00%) 09/17/20 Caixabank, Bankia boards approve merger agreement, Reuters reports 09/03/20 Bankia, Caixabank say they are considering merger, Bloomberg says

Periodicals	Tesla lowers Model 3 prices in Europe, Electrek reports » 11:35 01/20/21 01/20 11:35 01/20/21 11:35 TSLA Tesla $844.31 / -0.26 (-0.03%) Tesla has reduced Model 3… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options TSLA Tesla $844.31 / -0.26 (-0.03%) 01/19/21 EU passenger car registrations down 3.3% in December 01/14/21 Tesla director sells 10K shares of common stock 01/14/21 DPW Holdings subsidiary announces acceptance of pre-orders for EV charger 01/13/21 Tesla Model Y achieves 5-Star overall safety rating from NHTSA TSLA Tesla $844.31 / -0.26 (-0.03%) 09:16 Today JPMorgan JPMorgan boosts GM target to $63, calls 'significant contender' in autonomous 07:39 Today Deutsche Bank Tesla price target raised to $890 from $705 at Deutsche Bank 06:48 Today Oppenheimer Tesla price target raised to $1,036 from $486 at Oppenheimer 01/19/21 Jefferies Tesla price target raised to $775 from $650 at Jefferies TSLA Tesla $844.31 / -0.26 (-0.03%) 10/21/20 Tesla reports Q3 non-GAAP EPS 76c, consensus 56c 10/21/20 Notable companies reporting after market close 07/22/20 Tesla reports Q2 adjusted EPS 50c, consensus (11c) 07/22/20 Notable companies reporting after market close 14 Feb TSLA Tesla $844.31 / -0.26 (-0.03%) 01/19/21 Amazon and Ford backed EV Truck-maker Rivian raises another $2.65B, WSJ says 01/19/21 Tesla asks NHTSA to declare display issue 'inconsequential,' Reuters reports 01/18/21 Tesla says Model Y deliveries in China have officially begun 01/13/21 NHTSA asks Tesla to recall 158,000 cars over faulty touchscreens, Reuters says TSLA Tesla $844.31 / -0.26 (-0.03%) 01/14/21 Fly Intel: Pre-market Movers 01/11/21 NIO jumps after unveiling new luxury sedan to rival Tesla 01/08/21 Fly Intel: Pre-market Movers 01/06/21 Fly Intel: Pre-market Movers 01/27/21 Tesla - TSLA TSLA Tesla $844.31 / -0.26 (-0.03%) 08:55 Today Notable open interest changes for January 20th 01/13/21 Notable open interest changes for January 13th 01/12/21 Notable open interest changes for January 12th 01/11/21 Notable open interest changes for January 11th
Recommendations	Banco de Sabadell price target raised to EUR 0.40 from EUR 0.27 at UBS » 11:35 01/20/21 01/20 11:35 01/20/21 11:35 BNDSF Banco de Sabadell $0.00 / + (+0.00%) UBS analyst Ignacio… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Periodicals BNDSF Banco de Sabadell $0.00 / + (+0.00%) 11/27/20 Keefe Bruyette Sabadell downgraded to Underperform from Market Perform at Keefe Bruyette 11/05/20 UBS Banco de Sabadell price target lowered to EUR 0.27 from EUR 0.28 at UBS 11/03/20 Deutsche Bank Banco de Sabadell price target raised to EUR 0.45 at Deutsche Bank 10/20/20 UBS Banco de Sabadell price target lowered to EUR 0.28 from EUR 0.30 at UBS BNDSF Banco de Sabadell $0.00 / + (+0.00%) 09/08/20 Sabadell exploring strategic options, Bloomberg reports
Recommendations	Bayer price target raised to EUR 55 from EUR 47 at Credit Suisse » 11:33 01/20/21 01/20 11:33 01/20/21 11:33 BAYRY Bayer $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BAYRY Bayer $0.00 / + (+0.00%) 01/08/21 Argenx expects 2021 cash burn 'approximately doubling' compared to 2020 01/08/21 Bayer says FDA approves addition of OS and other data to Nubeqa prescribing info 01/07/21 Bayer signs collaboration, services agreement with CureVac for COVID-19 vaccine 12/22/20 Bayer, Veracyte announce new collaboration to advance precision oncology BAYRY Bayer $0.00 / + (+0.00%) 01/08/21 Morgan Stanley Bayer price target lowered to EUR 66 from EUR 67 at Morgan Stanley 01/07/21 Morgan Stanley CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley 12/07/20 Stifel Atara Biotherapeutics price target raised to $33 from $28 at Stifel 12/07/20 Roth Capital Bayer collaboration a testament to Atara's T-cell prowess, says Roth Capital BAYRY Bayer $0.00 / + (+0.00%) 11/03/20 Bayer confirms FY20 targets, sees core EPS EUR6.70-EUR6.90 11/03/20 Bayer reports Q3 core EPS down 30.2% to EUR0.81 09/30/20 Bayer confirms 2020 adjusted view, sees 2021 core EPS 'slightly' down from 2020 09/30/20 Bayer expects 2021 sales at approximately 2020 levels BAYRY Bayer $0.00 / + (+0.00%) 01/06/21 CureVac, Bayer reach alliance deal over COVID-19 vaccine, Reuters says 10/27/20 EPA clears use of Bayer's XtendiMax for five years, Reuters reports 10/11/20 Bayer, BASF fighting to keep weedkiller on U.S. farms, WSJ reports 09/15/20 Bayer resolves thousands of U.S. Roundup cases with trial lawyers, Reuters says BAYRY Bayer $0.00 / + (+0.00%) 01/07/21 Fly Intel: Pre-market Movers 00:00 Today PDUFA Date for Vericiguat
Recommendations	Grifols price target lowered to EUR 26 from EUR 27 at Credit Suisse » 11:32 01/20/21 01/20 11:32 01/20/21 11:32 GRFS Grifols $19.38 / -0.4 (-2.02%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly GRFS Grifols $19.38 / -0.4 (-2.02%) 01/18/21 Grifols to begin clinical trial in Spain for new COVID-19 drug 11/13/20 Soros takes stake in Palantir, exits TransDigm position 11/09/20 Grifols acquires remaining 49% of Goetech for $60.2M 10/09/20 Grifols begins anti-SARS-CoV-2 hyperimmune globulin trial GRFS Grifols $19.38 / -0.4 (-2.02%) 01/13/21 Morgan Stanley Grifols price target lowered to EUR 31 from EUR 32 at Morgan Stanley 12/09/20 Morgan Stanley Grifols price target raised to EUR 32 from EUR 31 at Morgan Stanley 11/06/20 Morgan Stanley Grifols price target raised to EUR 31 from EUR 30 at Morgan Stanley 10/30/20 Berenberg Grifols price target lowered to EUR 24.50 from EUR 25.30 at Berenberg GRFS Grifols $19.38 / -0.4 (-2.02%) 09/01/20 NIH says not enough evidence to recommend convalescent plasma, Bloomberg reports 09/01/20 NIH panel says data fail to back EUA for convalescent plasma, Bloomberg reports GRFS Grifols $19.38 / -0.4 (-2.02%) 08/24/20 Plasma producers spike after EUA issued for convalescent plasma to treat COVID 08/24/20 Fly Intel: Pre-market Movers
Recommendations	Orion Oyj price target raised to EUR 35 from EUR 30 at Credit Suisse » 11:32 01/20/21 01/20 11:32 01/20/21 11:32 ORINF Orion Oyj $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

Recommendations	Ahold Delhaize price target lowered to EUR 24 from EUR 25 at Credit Suisse » 11:30 01/20/21 01/20 11:30 01/20/21 11:30 ADRNY Ahold Delhaize $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research ADRNY Ahold Delhaize $0.00 / + (+0.00%) 11/18/20 Ahold Delhaize, Centerbridge Partners to buy FreshDirect, terms not disclosed ADRNY Ahold Delhaize $0.00 / + (+0.00%) 11/20/20 Stifel Ahold Delhaize upgraded to Hold from Sell at Stifel 11/10/20 Morgan Stanley Ahold Delhaize price target raised to EUR 25.40 from EUR 25 at Morgan Stanley 11/09/20 Credit Suisse Ahold Delhaize initiated with a Neutral at Credit Suisse 11/05/20 JPMorgan Ahold Delhaize price target lowered to EUR 22 from EUR 23 at JPMorgan
Recommendations	easyJet price target raised to 934 GBp from 840 GBp at Credit Suisse » 11:29 01/20/21 01/20 11:29 01/20/21 11:29 ESYJY easyJet $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Periodicals ESYJY easyJet $0.00 / + (+0.00%) 12/31/20 Fly Intel: Top five analyst calls 12/31/20 Citi easyJet downgraded to Sell from Neutral at Citi 12/17/20 Morgan Stanley easyJet price target raised to 900 GBp from 800 GBp at Morgan Stanley 12/14/20 AlphaValue easyJet upgraded to Reduce from Sell at AlphaValue ESYJY easyJet $0.00 / + (+0.00%) 12/22/20 Germany extends U.K. travel ban to January 6, Sky News reports
Recommendations	KBC Group price target lowered to EUR 60 from EUR 61 at Deutsche Bank » 11:27 01/20/21 01/20 11:27 01/20/21 11:27 KBCSY KBC Group $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research KBCSY KBC Group $0.00 / + (+0.00%) 01/14/21 Morgan Stanley KBC Group price target raised to EUR 71 from EUR 67 at Morgan Stanley 01/11/21 Deutsche Bank KBC Group downgraded to Hold from Buy at Deutsche Bank 01/07/21 Credit Suisse KBC Group downgraded to Neutral from Outperform at Credit Suisse 01/07/21 Credit Suisse KBC Group downgraded to Neutral from Outperform at Credit Suisse
Recommendations	Carl Zeiss Meditec price target raised to EUR 140 from EUR 120 at Deutsche Bank » 11:26 01/20/21 01/20 11:26 01/20/21 11:26 CZMWY Carl Zeiss Meditec $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research CZMWY Carl Zeiss Meditec $0.00 / + (+0.00%) 10/07/20 Microsoft, Zeiss announce multi-year strategic partnership CZMWY Carl Zeiss Meditec $0.00 / + (+0.00%) 11/02/20 Deutsche Bank Carl Zeiss Meditec price target raised to EUR 120 from EUR 110 at Deutsche Bank 10/23/20 UBS Carl Zeiss Meditec downgraded to Neutral from Buy at UBS 07/17/20 Berenberg Carl Zeiss Meditec price target raised to EUR 87 from EUR 81 at Berenberg 07/16/20 Deutsche Bank Carl Zeiss Meditec price target lowered to EUR 110 at Deutsche Bank
Recommendations	AirBoss of America price target lowered to C$28 from C$31 at CIBC » 11:20 01/20/21 01/20 11:20 01/20/21 11:20 ABSSF AirBoss of America $0.00 / + (+0.00%) CIBC analyst Scott… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ABSSF AirBoss of America $0.00 / + (+0.00%) 10/26/20 AirBoss of America acquires 100% ownership of Airboss Defense Group 10/05/20 AirBoss of America announces $22M in awards across ADG's survivability portfolio 09/28/20 AirBoss of America announces Husky long-term contract extension ABSSF AirBoss of America $0.00 / + (+0.00%) 01/14/21 Canaccord AirBoss of America price target lowered to C$27 from C$43 at Canaccord 12/18/20 TD Securities AirBoss of America price target lowered to C$29 from C$32 at TD Securities 11/12/20 Stifel AirBoss of America price target lowered to C$33 from C$34 at Stifel 11/12/20 TD Securities AirBoss of America price target raised to C$32 from C$31 at TD Securities ABSSF AirBoss of America $0.00 / + (+0.00%) 01/19/21 AirBoss of America sees 2020 revenue $498M-$503M

Options	Vertical call spread in energy ETF targets 26% return for 2021 » 11:20 01/20/21 01/20 11:20 01/20/21 11:20 XLE Energy Select Sector SPDR $43.50 / -0.12 (-0.28%) Vertical call spread in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Options Technical Analysis XLE Energy Select Sector SPDR $43.50 / -0.12 (-0.28%) 12/29/20 Alpha One Capital's Dan Niles likes JPMorgan, Oracle, Magna Intl, Gan Ltd in '21 08/05/20 Energy shares surge amid spike in natural gas, crude inventory drop XLE Energy Select Sector SPDR $43.50 / -0.12 (-0.28%) 07/06/20 Goldman Sachs Rattler Midstream downgraded to Neutral from Buy at Goldman Sachs XLE Energy Select Sector SPDR $43.50 / -0.12 (-0.28%) 01/08/21 Size call sale in Energy ETF likely closes December trade 12/14/20 Unusually active option classes on open December 14th XLE Energy Select Sector SPDR $43.50 / -0.12 (-0.28%) 08:25 Today Energy Select Sector SPDR: Pivot points 01/15/21 On The Fly: Weekly technical notes for S&P 500 01/15/21 Energy Select Sector SPDR: Pivot points 01/14/21 Energy Select Sector SPDR: Pivot points
Periodicals	Brookfield, KKR mull offers for $10B Aramco pipeline stake, Bloomberg says » 11:18 01/20/21 01/20 11:18 01/20/21 11:18 BAM Brookfield $38.51 / +0.18 (+0.47%) , KKR KKR $41.52 / +0.55 (+1.34%) , APO Apollo Global $48.08 / -0.1 (-0.21%) Brookfield Asset… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options BAM KKR APO BAM Brookfield $38.51 / +0.18 (+0.47%) 01/04/21 Brookfield Property establishes committee to review Brookfield proposal 01/04/21 Brookfield proposes to acquire remaining Brookfield Property units for $5.9B 12/30/20 JCPenney replacing CEO Jill Soltau, Stanley Shashoua stepping in for now 12/14/20 Blackstone unit BPPLS to acquire portfolio of lab properties for $3.45B KKR KKR $41.52 / +0.55 (+1.34%) 01/13/21 KKR closes first Asia real estate Fund at $1.7B 01/13/21 Fiserv, KKR called out as best ideas by Oakmark's Bill Nygren 01/12/21 KKR expands real estate industrial portfolio in Phoenix 01/11/21 KKR invests in music catalog of Ryan Tedder and OneRepublic APO Apollo Global $48.08 / -0.1 (-0.21%) 01/04/21 Takkion Holdings acquires Renew Energy; terms not disclosed 12/23/20 Apollo-led group to acquire 49.9% stake in AB InBev U.S. metal container plants 12/21/20 Apollo agrees to increase Great Canadian Gaming purchase price to C$45 per share 12/15/20 Cardtronics transaction indicates enterprise value of $2.3B, including net debt BAM KKR APO BAM Brookfield $38.51 / +0.18 (+0.47%) 01/05/21 JPMorgan Brookfield deal 'value accretive and multiple enhancing,' says JPMorgan 12/23/20 RBC Capital Brookfield assumed with an Outperform at RBC Capital 11/18/20 Fly Intel: Top five analyst initiations 11/18/20 Goldman Sachs Brookfield initiated with a Conviction Buy at Goldman Sachs KKR KKR $41.52 / +0.55 (+1.34%) 01/11/21 Citi Citi opens 'positive Catalyst Watches' on Invesco, Carlyle, KKR 11/11/20 Deutsche Bank KKR price target raised to $40 from $38 at Deutsche Bank 08/05/20 Citi Citi adds KKR to U.S. Focus List, ups price target to $47.50 07/09/20 Keefe Bruyette KKR price target raised to $41 from $34 at Keefe Bruyette APO Apollo Global $48.08 / -0.1 (-0.21%) 09:15 Today Truist Athene Holding price target raised to $55 from $48 at Truist 01/11/21 Wells Fargo Apollo Global price target raised to $55 from $50 at Wells Fargo 12/18/20 Deutsche Bank Apollo Global price target raised to $51 from $49 at Deutsche Bank 11/06/20 Fly Intel: Top five analyst upgrades BAM KKR APO BAM Brookfield $38.51 / +0.18 (+0.47%) 11/12/20 Brookfield reports Q3 EPS 10c, consensus 47c 08/13/20 Brookfield reports Q2 EPS (43c), consensus 39c KKR KKR $41.52 / +0.55 (+1.34%) 10/30/20 KKR reports Q3 EPS 48c, consensus 40c 08/04/20 KKR reports Q2 adjusted EPS 39c, consensus 36c 08/03/20 Notable companies reporting before tomorrow's open 08/03/20 Notable companies reporting before tomorrow's open APO Apollo Global $48.08 / -0.1 (-0.21%) 10/29/20 Apollo Global reports Q3 fee-related EPS 63c, consensus 49c 10/28/20 Notable companies reporting before tomorrow's open 10/28/20 Notable companies reporting before tomorrow's open 07/30/20 Apollo Global reports Q2 fee-related EPS 59c, consensus 48c 11 Nov BAM KKR APO BAM Brookfield $38.51 / +0.18 (+0.47%) 11/10/20 Brookfield seeks to enter secondary market for private assets, Bloomberg says 10/25/20 Blackstone to buy Simply Self storage for $1.2B, WSJ reports 10/22/20 JCPenney's new owners reject pension plan, Dallas Morning News reports 10/19/20 Brookfield investing $2B in biggest Indian property deal yet, Bloomberg says KKR KKR $41.52 / +0.55 (+1.34%) 01/13/21 KKR closes inaugural APAC real estate fund at $1.7B, Reuters says 11/19/20 Bain, KKR weigh offers for Hitachi Metals, Nikkei Asia reports 11/18/20 Epic, Spotify not impressed with Apple App Store policy update, CNBC says 11/05/20 'Fortnite' to be playable on iOS devices via Nvidia GeForce, BBC reports APO Apollo Global $48.08 / -0.1 (-0.21%) 01/08/21 NCR in talks to bid against Apollo for Cardtronics, WSJ reports 01/08/21 NCR in talks to bid against Apollo for Cardtronics, WSJ reports 12/11/20 Apollo, Blackstone in talks for Wells Fargo student loan book, Bloomberg says 12/11/20 Apollo, Blackstone in talks for Wells Fargo student loan book, Bloomberg says APO APO Apollo Global $48.08 / -0.1 (-0.21%) 09/25/20 Sports betting space gains after William Hill receives two takeover offers 09/25/20 Fly Intel: Pre-market Movers 09/24/20 SPACs under pressure as SEC chairman voices disclosure concerns 09/03/20 Tesla slides as investor trims stake, QuantumScape joins EV SPAC craze 02/24/21 22nd Annual Virtual Financial Services Forum 02/03/21 Apollo Global - APO 02/11/21 Brookfield - BAM APO APO Apollo Global $48.08 / -0.1 (-0.21%) 10/22/20 Apollo Global put volume heavy and directionally bearish
Syndicate	Oyster Enterprises Acquisition opens at $10.17, IPO priced at $10 per unit » 11:18 01/20/21 01/20 11:18 01/20/21 11:18 OSTR Oyster Enterprises Acquisition $0.00 / + (+0.00%) Oyster Enterprises… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Technical Analysis	NASDAQ market internals summary » 11:17 01/20/21 01/20 11:17 01/20/21 11:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 10:17 Today NASDAQ market internals summary 01/19/21 NASDAQ market internals summary 01/19/21 NASDAQ market internals summary 01/19/21 NASDAQ market internals summary
Recommendations	Travis Perkins price target raised to 1,450 GBp from 1,360 GBp at Canaccord » 11:15 01/20/21 01/20 11:15 01/20/21 11:15 TVPKF Travis Perkins $0.00 / + (+0.00%) Canaccord analyst Aynsley… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research TVPKF Travis Perkins $0.00 / + (+0.00%) 01/08/21 JPMorgan Travis Perkins upgraded to Neutral from Underweight at JPMorgan 12/18/20 RBC Capital Travis Perkins price target raised to 1,300 GBp from 1,250 GBp at RBC Capital 04/08/20 JPMorgan Travis Perkins downgraded to Underweight from Neutral at JPMorgan

Events

Earnings calls, analyst events, roadshows and more

Today at 12:00

Software & Internet Industry Meetings
Today at 13:00

Software & Internet Industry Meetings
Today at 14:00

Food/Agribusiness Industry Meetings
Today at 14:00

Energy Transition Industry Meetings
KMI
Today at 16:30

Kinder Morgan - KMI Conference Calls
AA
Today at 17:00

Alcoa - AA Conference Calls
HWC
Today at 17:00

Hancock Whitney - HWC Conference Calls
NVEC
Today at 17:00

NVE Corp. - NVEC Conference Calls
AGN ...
Tomorrow at 00:00

Aesthetics Tech Virtual Summit 2021 Conferences

Virtual Summit
Tomorrow at 00:00

2021 Conservation Finance Virtual Conference Conferences

Virtual Conference

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley $25.50-26.50 700K Shares
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush $12.00-15.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen $24.00-26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities $26.55 4M Shares CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright $93.33 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler $8.48 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $76.12 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel $28.61 5.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse $72.11 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink $24.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $ Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Forte Biosciences $30M Spot Secondary re-offered at $28.50

TODAY'S FREE FLY STORIES

Get Full Fly Access